NCT07562334 Assessment of Soft Tissue Thickness Following Utilization of Buccal Pad of Fat Versus Platelet-rich Fibrin for Covering Zygomatic Implants: A Randomized Clinical Trial
| NCT ID | NCT07562334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Soft Tissue Augmentation at Dental Implants |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-12-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Would buccal pad of fat be comparable to platelet rich fibrin for Zygomatic implant coverage as a step for reconstruction of atrophic posterior maxilla, in terms of peri-implant soft tissue thickness and avoiding complicated postoperative sequalae?
Eligibility Criteria
Inclusion Criteria: 1. Patients with severely atrophic edentulous upper arch (Cawood class IV, V, VI) that could not be restored by other type of treatment 2. Patients who had at least 8-12 mm vertical bone height in anterior maxilla to allow installation of 2 conventional implants. 3. Lacking posterior maxillary bone support due to significant sinus pneumatization 4. Good systemic health (ASA score I-II) 5. Highly motivated patients Exclusion Criteria: 1. Patient not willing to give his/her informed consent. 2. Patients with systemic disease that did not permit the surgical procedure (including general anesthesia). 3. Patients with uncontrolled diabetes or under bisphosphonate therapy. 4. Heavy smoker. (\> 20 cigarettes daily) 5. Patient with psychiatric problems, severe bruxism or other parafunctional habits. 6. Acute sinusitis. 7. Malignancy or pathology in Maxilla or Zygoma.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07562334 clinical trial?
This trial is open to participants of all sexes, studying Soft Tissue Augmentation at Dental Implants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07562334 currently recruiting?
Yes, NCT07562334 is actively recruiting participants. Contact the research team at caroline.john@dentistry.cu.edu.eg for enrollment information.
Where is the NCT07562334 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07562334 clinical trial?
NCT07562334 is sponsored by Cairo University. The trial plans to enroll 24 participants.